4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-25-030285
Chief Operating Officer gave up 1,896 shares (to pay taxes)
- Chief Operating Officer acquired 4,327 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cittadine Andrew Chief Operating Officer | 2025-09-30 | Option exercise | +4,327 | 50,185 | D | ||
| Cittadine Andrew Chief Operating Officer | 2025-09-30 | Shares withheld for taxes | −1,896 | $81.67 | $154,846 | 48,289 | D |
| Derivatives | |||||||
| Cittadine Andrew Chief Operating Officer | 2025-09-30 | Option exercise · Restricted Stock Units | −4,327 | 38,674 | D | ||
Loading xslF345X05/rdgdoc.xml…